Twin epidemics: The surging rise of methamphetamine use in chronic opioid users

Drug and Alcohol Dependence

Volumn 193, Issue , 2018, Pages 14-20

  Ellis, Matthew S ^a   Kasper, Zachary A ^a   Cicero, Theodore J ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

Methamphetamine; Opioids; Polysubstance use

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DRUG USE; DSM-IV; FEMALE; HELP SEEKING BEHAVIOR; HUMAN; MALE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITATIVE RESEARCH; RURAL AREA; SELF REPORT; UNITED STATES; URBAN AREA; ADOLESCENT; AMPHETAMINE DEPENDENCE; MIDDLE AGED; OPIATE ADDICTION; QUESTIONNAIRE; RURAL POPULATION; STATISTICS AND NUMERICAL DATA; TRENDS; URBAN POPULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; FEMALE; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PREVALENCE; RURAL POPULATION; SURVEYS AND QUESTIONNAIRES; UNITED STATES; URBAN POPULATION; YOUNG ADULT;

EID: 85054657775     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2018.08.029     Document Type: Article

References (32)

1. Alford, D.P., Opioid prescribing for chronic pain—achieving the right balance through education. N. Engl. J. Med. 374 (2016), 301–303.
2. Brady, J.E., Wunsch, H., DiMaggio, C., Lang, B.H., Giglio, J., Li, G., Prescription drug monitoring and dispensing of prescription opioids. Public Health Rep. 129 (2014), 139–147.
3. Bremer, P.T., Schlosburg, J.E., Banks, M.L., Steele, F.F., Zhou, B., Poklis, J.L., Janda, K.D., Development of a clinically viable heroin vaccine. J. Am. Chem. Soc. 139 (2017), 8601–8611.
4. Center for Behavioral Health Statistics and Quality, Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health. HHS Publication No. SMA 15-4927, NSDUH Series H-50. Available at, 2015 http://www.samhsa.gov/data/.
5. Center for Substance Abuse Treatment, Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2004 Available at https://www.ncbi.nlm.nih.gov/pubmed/22514846.
6. Cicero, T.J., Ellis, M.S., Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: lessons learned from OxyContin. JAMA Psychiatry 72 (2015), 424–430.
7. ® ). Pain Med. 8 (2007), 157–170.
8. Cicero, T.J., Ellis, M.S., Surratt, H.L., Kurtz, S.P., The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry 71 (2014), 821–826.
9. Cicero, T.J., Ellis, M.S., Kasper, Z.A., Understanding the demand side of the prescription opioid epidemic: does the initial source of opioids matter?. Drug Alcohol Depend. 173 (2017), S4–S10.
10. Compton, W.M., Jones, C.M., Baldwin, G.T., Relationship between nonmedical prescription-opioid use and heroin use. N. Engl. J. Med. 374 (2016), 154–163.
11. Dart, R.C., Surratt, H.L., Cicero, T.J., Parrino, M.W., Severtson, S.G., Bucher-Bartelson, B., Green, J.L., Trends in opioid analgesic abuse and mortality in the United States. N. Engl. J. Med. 372 (2015), 241–248.
12. Dart, R.C., Surratt, H.L., Cicero, T.J., Parrino, M.W., Severtson, S.G., Bucher-Bartelson, B., Green, J.L., Supplementary Appendix: trends in opioid analgesic abuse and mortality in the United States. N. Eng. J. Med. 372 (2015), 241–248.
13. DuPont, R.L., The opioid epidemic is an historic opportunity to improve both prevention and treatment. Brain Res. Bull. 138 (2018), 112–114.
14. Guy, G.P. Jr., Zhang, K., Bohm, M.K., Losby, J., Lewis, B., Young, R., Murphy, L.B., Dowell, D., Vital signs: changes in opioid prescribing in the United States, 2006–2015. MMWR Morb. Mortal. Wkly. Rep. 66 (2017), 697–704.
15. International Narcotics Control Board, Report of the International Narcotics Control Board for 2008. Available at:, 2009, United Nations Publications, New York, NY https://www.incb.org/incb/en/publications/annual-reports/annual-report-2008.html.
16. Kuppili, P.P., Manohar, H., Menon, V., Current state of vaccines in psychiatry—a narrative review. Asian J. Psychiatry 31 (2018), 112–120.
17. Lipari, R.N., Williams, M., Van Horn, S.L., Why Do Adults Misuse Prescription Drugs? The CBHSQ Report. Available at:, 2017, Substance Abuse and Mental Health Services Administration (US), Rockville (MD) https://www.samhsa.gov/data/sites/default/files/report_3210/ShortReport-3210.html.
18. Loza, O., Ramos, R., Ferreira-Pinto, J., Hernandez, M.T., Villalobos, S.A., A qualitative exploration of perceived gender differences in methamphetamine use among women who use methamphetamine on the Mexico-U.S. border. J. Ethn. Subst. Abuse 15 (2016), 405–424.
19. Maxwell, J.C., The prescription drug epidemic in the United States: a perfect storm. Drug Alcohol Rev. 30 (2011), 264–270.
20. McHugh, R.K., Nielsen, S., Weiss, R.D., Prescription drug abuse: from epidemiology to public policy. J. Subst. Abuse Treat. 48 (2015), 1–7.
21. Meacham, M.C., Strathdee, S.A., Rangel, G., Armenta, R.F., Gaines, T.L., Garfein, R.S., Prevalence and correlates of heroin-methamphetamine co-injection among persons who inject drugs in San Diego, California, and Tijuana, Baja California, Mexico. J. Stud. Alcohol Drugs 77 (2016), 774–781.
22. Montemayor, S., In the Shadow of the Opioid Crisis, Meth Has Roared Back into Minnesota. 2018, Star Tribune, Minneapolis May 29 http://m.startribune.com/minnesota-opioid-deaths-rise-despite-attention-intervention/424836053/.
23. Mori, T., Iwase, Y., Saeki, T., Iwata, N., Murata, A., Masukawa, D., Suzuki, T., Differential activation of dopaminergic systems in rat brain basal ganglia by morphine and methamphetamine. Neuroscience 322 (2016), 164–170.
24. National Institute on Drug Abuse, National Survey of Drug Use and Health: Trends in Prevalence of Various Drugs from Ages 12 or Older, Ages 12 to 17, Ages 18 to 25, and Ages 26 or Older; 2015–2016. Available at:, 2018 https://www.drugabuse.gov/national-survey-drug-use-health.
25. O'Donnell, J.K., Halpin, J., Mattson, C.L., Goldberger, B.A., Gladden, R.M., Deaths involving fentanyl, fentanyl analogs, and U-47700-10 States, July–December 2016. MMWR Morb. Mortal. Wkly. Rep. 66 (2017), 1197–1202.
26. Olson, M.E., Janda, K.D., Vaccines to combat the opioid crisis. Vaccines that prevent opioids and other substances of abuse from entering the brain could effectively treat addiction and abuse. EMBO Rep. 19 (2018), 5–9.
27. Robles, F., Meth, the Forgotten Killer, is Back. And It's Everywhere. Retrieved from, 2018, The New York Times https://www.nytimes.com/2018/02/13/us/meth-crystal-drug.html.
28. Seth, P., Scholl, L., Rudd, R.A., Bacon, S., Overdose deaths involving opioids, cocaine, and psychostimulants – United States, 2015–2016. MMWR Morb. Mortal. Wkly. Rep. 67 (2018), 349–358.
29. Soelberg, C.D., Brown, R.E. Jr., Du Vivier, D., Meyer, J.E., Ramachandran, B.K., The US opioid crisis: current federal and state legal issues. Anesth. Analg. 125 (2017), 1675–1681.
30. U.S. Customs and Border Protection, CBP Enforcement Statistics FY. Accessed at, 2018 on May 30, 2018 https://www.cbp.gov/newsroom/stats/cbp-enforcement-statistics.
31. U.S. Department of Justice, Drug Enforcement Administration, 2017 National Drug Threat Assessment. DEA-DCT-DIR-040-17. Available at:, 2017 https://www.dea.gov/documents/2017/10/01/2017-national-drug-threat-assessment.
32. Wilkerson, R.G., Kim, H.K., Windsor, T.A., Mareiniss, D.P., The opioid epidemic in the United States. Emerg. Med. Clin. North Am. 34 (2016), e1–e23.